Skip to main content
. 2024 Dec 10;22:100601. doi: 10.1016/j.jvacx.2024.100601

Table 2.

Comparison of KECIP with other National Immunization Technical Advisory Groups.

Characteristics Korea (KECIP) United States (ACIP) United
Kingdom (JCVI)
Australia (ATAGI) Canada (NACI)
Establishment Year Established in 1992 (Elevated to legal entity in 1994) Established in 1964 (Designated as federal advisory committee in 1972) Established in 1963 (Permanent advisory committee in 1981) Established in 1997 Established in 1964 (Renamed in 1978)
Legal Basis Infectious Disease Control and Prevention Act Public Health Service Act NHS Act National Health Act
Decision-Making Process Majority vote of attending members (Majority of registered members for written meetings) Voting Consensus based on expert opinions Voting (Consensus if possible, Chair has casting vote in case of tie) Voting
Committee Composition Up to 15 members 15 voting members, 6 ex officio members, 30 non-voting liaison organization representatives 16 members (varies by period) 15 standing voting members, 4 ex officio members 15 voting members, 9 non-voting members, 6 ex officio members
Conflict of Interest Disclosure Mandatory disclosure (Submission of conflict of interest declaration) Verification before meetings and voting (Members with vaccine company interests ineligible) Members with interests may participate in discussions but not decision-making Decide whether to exclude from meeting or decision-making based on interests Members with interests excluded from voting
Member Term Appointed members: 2 years (Nominated members: duration of position) 4 years (Chair: 3 years) Maximum 3 years (Renewable, not exceeding 10 years) Standing members: maximum 4 years Members: 4 years (renewable once), Chair/Vice-Chair: 2 years (maximum 4 years)
Operating Budget 7,000,000 KRW (2022) $514,560 (including member compensation and travel expenses) No allocated budget Funded by Department of Health, partial pharmaceutical company support
Meeting Frequency Biannual regular meetings (ad hoc meetings as needed) Triannual regular meetings Triannual meetings (additional meetings in emergencies) Six regular meetings annually (two via videoconference) Three face-to-face meetings annually (monthly videoconferences)
Meeting Transparency Principally open (individuals and corporations may observe) Webcast (Schedule announced at least 15 days in advance) Observers (government and agency representatives, not general public) Meeting dates posted on ATAGI website at least 12 months in advance Closed
Minutes Publication Published via information and communication networks Published on ACIP website within 90 days post-meeting Published on website within 6 weeks post-meeting Published on website at least 6 weeks post-meeting Summary of minutes published
Member Notification Schedule notified 7 days pre-meeting Schedule announced at least 15 days pre-meeting Meeting notice 7 days in advance Agenda notified at least 4 weeks pre-meeting Schedule posted on website 12 months in advance, agenda shared pre-meeting
Subcommittee Operation Not operated Operated Operated Operated Operated
Subcommittee Role ACIP member support (data collection, analysis, effectiveness review); Monthly remote meetings (minutes confidential) JCVI member support (literature and vaccine efficacy review); Meetings as needed (minutes published post-JCVI approval) ATAGI member support (vaccine utility, prioritization, distribution, safety assessment) NACI member support (draft preparation for discussion/voting)
Additional Notes Operation of Expert Advisory Group on Immunization (consultation on specialized knowledge, investigation, and analysis) Subcommittees operate as 3 subgroups Subcommittees established as needed for NACI workplan (meetings biweekly)

Abbreviation. KECIP, Korea Expert Committee on Immunization Practices; ACIP, Advisory Committee on Immunization Practices; JCVI, Joint Committee on Vaccination and Immunization; ATAGI, Australian Technical Advisory Group on Immunization; NACI, National Advisory Committee on Immunization.